Jacobs Levy Equity Management’s TRACON Pharmaceuticals TCON Stock Holding History
Bought
Maintained
Sold
Other funds holding TCON
6CM
TI
Jacobs Levy Equity Management's TCON Position: Q1 2019 in Review
Jacobs Levy Equity Management sold out of TRACON Pharmaceuticals (TCON) in Q1 2019, closing a stake of 491 shares — an estimated $62K sold.
Jacobs Levy Equity Management first reported a position in TCON in Q2 2016 and held it in 10 quarters. The position peaked at $348K in Q1 2018. 24 funds tracked by Wall St. Rank hold TCON as of Q1 2019.
- Jacobs Levy Equity Management reported no remaining TRACON Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
- Jacobs Levy Equity Management sold 491 TRACON Pharmaceuticals shares in Q1 2019, an estimated $62K.
- Jacobs Levy Equity Management first reported a position in TRACON Pharmaceuticals in Q2 2016 and held it in 10 quarters.
- Jacobs Levy Equity Management's TRACON Pharmaceuticals position peaked at $348K in Q1 2018.
- 24 funds tracked by Wall St. Rank held TRACON Pharmaceuticals as of Q1 2019.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.